TG THERAPEUTICS, INC. Total Assets
TG THERAPEUTICS, INC. (TGTX) had Total Assets of $1.64 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-05
- 2026-06-30: Assets $1.64B.
- 2026-03-31: Assets $1.53B.
- 2025-12-31: Assets $1.06B.
- 2025-09-30: Assets $1.03B.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $1.64B 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $1.53B 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $1.06B 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $1.03B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $702.61M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $656.69M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $577.69M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $586.01M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $401.21M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $373.32M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $329.59M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $331.07M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $220.85M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $197.36M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $193.57M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $217.89M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $251.67M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $303.03M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $379.63M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $409.69M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $481.40M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $548.70M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $625.64M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $273.86M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $294.62M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $101.85M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $163.01M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $93.33M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $106.58M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $117.54M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $83.62M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $114.37M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $140.72M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $120.99M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $97.38M 10-K · filed 2019-03-01 | $97.38M 10-K · filed 2018-03-15 |
| 2017-09-30 | $101.78M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $101.20M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $123.26M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $54.78M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $75.69M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $94.80M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $100.06M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $113.47M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $127.41M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $123.61M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $117.27M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $86.75M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $77.54M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $56.30M 10-Q · filed 2014-07-24 | |
| 2014-03-31 | $58.17M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $48.11M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $54.30M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $17.86M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $21.39M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $22.07M 10-K · filed 2014-03-07 | |
| 2012-09-30 | $25.23M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $26.53M 10-Q/A · filed 2012-09-07 | |
| 2012-03-31 | $27.07M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $14.54M 10-K · filed 2013-03-21 | $15.91M 10-K · filed 2012-03-14 |
| 2011-09-30 | $18.06M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $18.36M 10-Q/A · filed 2011-09-14 | |
| 2010-12-31 | $18.64M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |